CDC Website CDC Website

To Join the NPIN community or

You are here

TB

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

2017 State and City Tuberculosis Report

Edith Jickling's picture

This National TB Report publishes key process and outcomes measures for TB control programs in the United States to evaluate progress towards TB elimination.

Implementing The End TB Strategy: The Essentials

Edith Jickling's picture
2016 is the first year of implementation of the WHO End TB Strategy in the context of the United Nations Sustainable Development Goals Agenda, both of which include the aim of ending the TB epidemic. To support the work ahead, the World Health Organization’s Global TB Programme has developed operational guidance, The Essentials, for effective adaptation and implementation of the new Strategy. The Essentials provides in-depth explanations of the vision, goal, targets, and milestones of the End TB Strategy, as well as key indicators to measure progress.

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

Edith Jickling's picture
The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Rifampin

Edith Jickling's picture
The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Rifampin

Pratima Nimboorkar's picture
This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

TB Personal Stories - Kate

Edith Jickling's picture
This story highlights the personal experiences of a Tuberculosis (TB) survivor who was diagnosed and treated for TB disease. The survivor details the challenges of a lengthy hospital stay, her worries over how TB medicines would affect her pregnancy and baby, and her work as an advocate since recovering from TB.

Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit meritorious applications for the Tuberculosis Research Advancement Centers (TRACs) program. The main goal of these centers is to provide administrative and shared research support to foster and elevate multidisciplinary tuberculosis (TB) research and provide exceptional mentorship to New Investigators. TRACs will provide core facilities, services and mentoring opportunities to achieve the goals of the program.

Pages

Subscribe to RSS - TB